Subtherapeutic Kitasamycin Promoted Fat Accumulation in the Longissimus Dorsi Muscle in Growing-Finishing Pigs

Overview

Journal Animals (Basel)

Date 2024 Apr 13

PMID 38612296

Authors

Ge Han

Jie Yu

Jun He

Ping Zheng

Xiangbing Mao

Bing Yu

Affiliations

Soon will be listed here.

Abstract

Kitasamycin (KM), a broad-spectrum macrolide antibiotic, has implications for growth performance and residue in animals and humans. This study aimed to explore the effects of different KM doses on intramuscular fat accumulation, cecal microflora, and short-chain fatty acids (SCFAs) using a growing-finishing pig model. Forty-two pigs were divided into three groups: control, subtherapeutic KM (50 mg/kg, KM50), and therapeutic KM (200 mg/kg, KM200) diets over 8 weeks. KM50 led to increased back fat thickness, fat content in the longissimus dorsi muscle (LM), and elevated plasma total cholesterol (TC) levels ( < 0.05), supported by upregulated lipid synthesis gene expression (, , ) ( < 0.05) in the LM. KM50 altered cecal microflora, reducing spp. and spp. abundance, while increasing SCFA concentrations (acetic acid, propionic acid, total SCFAs) ( < 0.05). KM200 had minimal effects on intestinal weight and density, with increased apparent digestibility of nutrients. These findings highlight the dose-dependent impact of KM on intramuscular fat deposition. Subtherapeutic KM induced ectopic fat deposition, emphasizing potential risks in disease treatment for humans and animals.

References

Naslund J, Hedman J, Agestrand C . Effects of the antibiotic ciprofloxacin on the bacterial community structure and degradation of pyrene in marine sediment. Aquat Toxicol. 2008; 90(3):223-7. DOI: 10.1016/j.aquatox.2008.09.002. View

Hana C, Klebermass E, Balber T, Mitterhauser M, Quint R, Hirtl Y . Inhibition of Lipid Accumulation in Skeletal Muscle and Liver Cells: A Protective Mechanism of Bilirubin Against Diabetes Mellitus Type 2. Front Pharmacol. 2021; 11:636533. PMC: 7868327. DOI: 10.3389/fphar.2020.636533. View

Velagapudi V, Hezaveh R, Reigstad C, Gopalacharyulu P, Yetukuri L, Islam S . The gut microbiota modulates host energy and lipid metabolism in mice. J Lipid Res. 2009; 51(5):1101-12. PMC: 2853437. DOI: 10.1194/jlr.M002774. View

Sterenczak K, Fuellen G, Junemann A, Guthoff R, Stachs O, Stahnke T . The Antibiotic Kitasamycin-A Potential Agent for Specific Fibrosis Preventing Therapy after Fistulating Glaucoma Surgery?. Pharmaceutics. 2023; 15(2). PMC: 9960401. DOI: 10.3390/pharmaceutics15020329. View

Park S, Ustulin M, Park S, Han K, Kim J, Shin D . Systemic Antibiotics and Obesity: Analyses from a Population-Based Cohort. J Clin Med. 2021; 10(12). PMC: 8231544. DOI: 10.3390/jcm10122601. View

May K, den Hartigh L . Modulation of Adipocyte Metabolism by Microbial Short-Chain Fatty Acids. Nutrients. 2021; 13(10). PMC: 8538331. DOI: 10.3390/nu13103666. View

La T, Phillips N, Dunlop H, Lugsomya K, Coiacetto F, Hampson D . Testing the efficacy of kitasamycin for use in the control and treatment of swine dysentery in experimentally infected pigs. Aust Vet J. 2019; 97(11):452-464. DOI: 10.1111/avj.12876. View

Morrison D, Preston T . Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes. 2016; 7(3):189-200. PMC: 4939913. DOI: 10.1080/19490976.2015.1134082. View

Roubaud-Baudron C, Ruiz V, Swan Jr A, Vallance B, Ozkul C, Pei Z . Long-Term Effects of Early-Life Antibiotic Exposure on Resistance to Subsequent Bacterial Infection. mBio. 2019; 10(6). PMC: 6935859. DOI: 10.1128/mBio.02820-19. View

10.

Pfaffl M . A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001; 29(9):e45. PMC: 55695. DOI: 10.1093/nar/29.9.e45. View

11.

Cao X, Tang L, Zeng Z, Wang B, Zhou Y, Wang Q . Effects of Probiotics BaSC06 on Intestinal Digestion and Absorption, Antioxidant Capacity, Microbiota Composition, and Macrophage Polarization in Pigs for Fattening. Front Vet Sci. 2020; 7:570593. PMC: 7677304. DOI: 10.3389/fvets.2020.570593. View

12.

Yoon J, Ingale S, Kim J, Kim K, Lohakare J, Park Y . Effects of dietary supplementation with antimicrobial peptide-P5 on growth performance, apparent total tract digestibility, faecal and intestinal microflora and intestinal morphology of weanling pigs. J Sci Food Agric. 2012; 93(3):587-92. DOI: 10.1002/jsfa.5840. View

13.

Fierer N, Jackson J, Vilgalys R, Jackson R . Assessment of soil microbial community structure by use of taxon-specific quantitative PCR assays. Appl Environ Microbiol. 2005; 71(7):4117-20. PMC: 1169028. DOI: 10.1128/AEM.71.7.4117-4120.2005. View

14.

Lunney J, Van Goor A, Walker K, Hailstock T, Franklin J, Dai C . Importance of the pig as a human biomedical model. Sci Transl Med. 2021; 13(621):eabd5758. DOI: 10.1126/scitranslmed.abd5758. View

15.

Gilbert M . Role of skeletal muscle lipids in the pathogenesis of insulin resistance of obesity and type 2 diabetes. J Diabetes Investig. 2021; 12(11):1934-1941. PMC: 8565406. DOI: 10.1111/jdi.13614. View

16.

Cheng C, Ku H, Lin H . PGC-1α as a Pivotal Factor in Lipid and Metabolic Regulation. Int J Mol Sci. 2018; 19(11). PMC: 6274980. DOI: 10.3390/ijms19113447. View

17.

Ebrahimi F, Simon T, Hagstrom H, Sun J, Bergman D, Forss A . Antibiotic use and development of nonalcoholic fatty liver disease: A population-based case-control study. Liver Int. 2023; 43(10):2186-2197. DOI: 10.1111/liv.15663. View

18.

Livanos A, Greiner T, Vangay P, Pathmasiri W, Stewart D, McRitchie S . Antibiotic-mediated gut microbiome perturbation accelerates development of type 1 diabetes in mice. Nat Microbiol. 2016; 1(11):16140. PMC: 5808443. DOI: 10.1038/nmicrobiol.2016.140. View

19.

Chen Y, Liu K, Su Y, Zheng X, Wang Q . Continuous bioproduction of short-chain fatty acids from sludge enhanced by the combined use of surfactant and alkaline pH. Bioresour Technol. 2013; 140:97-102. DOI: 10.1016/j.biortech.2013.04.075. View

20.

Althaher A . An Overview of Hormone-Sensitive Lipase (HSL). ScientificWorldJournal. 2022; 2022:1964684. PMC: 9754850. DOI: 10.1155/2022/1964684. View